7-Epipaclitaxel is primarily investigated for its potential in cancer therapy, particularly in the treatment of various types of cancers such as breast, ovarian, and lung cancer. It functions similarly to paclitaxel by stabilizing microtubules, which prevents their disassembly and disrupts normal cellular division, leading to cancer cell death. This compound is of interest due to its potential to overcome drug resistance observed with paclitaxel in some cancer types. Research is ongoing to evaluate its efficacy, safety, and potential as an alternative or complementary treatment in chemotherapy regimens. Additionally, it is studied for its role in enhancing the effectiveness of other anticancer agents when used in combination therapies.